Testing new drugs for chronic kidney disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests different medicines to see if they can slow down kidney disease. You may be able to join if you have chronic kidney disease and are already getting standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have chronic kidney disease with a certain level of kidney function
- You are already receiving the usual care from your doctor
- You are willing to take part in the trial and follow the procedures
- You are not planning to start dialysis or have a kidney transplant in the next 6 months
- Your life expectancy is more than 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a once-daily pill called finerenone to see if it can reduce protein in the urine (a sign of kidney damage) in people with type 2 diabetes and chronic kidney disease. It may help protect your kidneys and slow down disease progression.
This trial tests if finerenone can protect kidneys in people with chronic kidney disease who are not taking common blood pressure medications called ACE inhibitors, ARBs, or renin inhibitors. It may help slow kidney damage.
This trial tests whether finerenone (a medicine that helps protect the kidneys) can improve recovery from acute kidney injury (sudden kidney failure) in hospitalized patients. Participation involves taking the study drug or a placebo while in the hospital.
This trial is testing a medication called finerenone to see how well it helps people with type 2 diabetes who also have chronic kidney disease. Researchers are looking at how the drug affects kidney function and related health factors.
This trial tests a medication called Finerenone to see if it can improve heart structure and function in people with both diabetic kidney disease and heart failure. If you have type 2 diabetes, kidney problems, and heart failure with preserved pumping function, this study may explore a new treatment option for you.
This trial tests if a medicine called finerenone can protect kidney function in people with type 2 diabetes and early-to-moderate chronic kidney disease. It may be an option if you are already on blood pressure medication and have some protein in your urine.
Hear when a new Chronic Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.